Development of autoantibodies in the TrialNet natural history study

Diabetes Care

Volumn 34, Issue 9, 2011, Pages 1897-1901

  Vehik, Kendra ^a   Beam, Craig A ^a   Mahon, Jeffrey L ^b   Schatz, Desmond A ^c   Haller, Michael J ^c   Sosenko, Jay M ^d   Skyler, Jay S ^d   Krischer, Jeffrey P ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; INSULIN ANTIBODY; INSULINOMA ASSOCIATED PROTEIN 2 ANTIBODY; UNCLASSIFIED DRUG; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; ICA512 AUTOANTIBODY; PTPRN PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; AGE; ARTICLE; CHILD; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; SCREENING; SEROCONVERSION; AGE DISTRIBUTION; BLOOD; IMMUNOLOGY; INFANT; PROPORTIONAL HAZARDS MODEL;

ADOLESCENT; AGE DISTRIBUTION; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; MALE; PROPORTIONAL HAZARDS MODELS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8;

EID: 84856689949     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0560     Document Type: Article

References (11)

1. Krischer JP, Cuthbertson DD, Yu L, et al. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 2003;88:103-108 (Pubitemid 36115150)
2. Vehik K, Haller MJ, Beam CA, et al.; DPT-1 Study Group. Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood. Diabetes Care 2011;34:358-362
3. Knip M, Korhonen S, Kulmala P, et al. Prediction of type 1 diabetes in the general population. Diabetes Care 2010;33:1206-1212
4. Schatz D, Krischer J, Horne G, et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 1994;93:2403-2407 (Pubitemid 24177152)
5. Ziegler AG, Hillebrand B, Rabl W, et al. On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study frombirth. Diabetologia 1993;36:402-408 (Pubitemid 23124043)
6. Leslie RD, Elliott RB. Early environmental events as a cause of IDDM. Evidence and implications. Diabetes 1994; 43:843-850
7. Colman PG, McNair PD, Gellert S, et al. Development of autoantibodies to islet antigens during childhood: implications for preclinical type 1 diabetes screening. Pediatr Diabetes 2002;3:144-148 (Pubitemid 35203521)
8. Mahon JL, Sosenko JM, Rafkin-Mervis L, et al.; TrialNet Natural History Committee; Type 1 Diabetes TrialNet Study Group. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes 2009;10:97-104
9. Wang J, Miao D, Babu S, et al. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab 2007;92:88-92 (Pubitemid 46075008)
10. Hahl J, Simell T, Ilonen J, Knip M, Simell O. Costs of predicting IDDM. Diabetologia 1998;41:79-85 (Pubitemid 28105745)
11. Achenbach P, Lampasona V, Landherr U, et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 2009;52:1881-1888